Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by prophetoffactzon Jan 08, 2024 9:17am
80 Views
Post# 35815326

RE:RE:fossi doesn't want people to talk about it.

RE:RE:fossi doesn't want people to talk about it.
Fossi hyped CZO's step-wise development plan for PGX 
as a "MUST" and "in the right framework" less than nine months ago.
For fossi it was the most promising development point as fossi promoted
a potential tripling of sales towards 2026. Now the 5X scale-up is set to
be commisisoned in Q1 and Natex is working on the 10X scale-up
with 50% of the equipment and infrastructure in place as of Nov. Ronnie is "thrilled"
with how AEZS can complement CZO's growth plan and AEZS's Chair
believes AEZS's capital can complment CZO's growth plan. fossi doesn't 
want anyone talking about the PGX plan as Gilles also informed shareholders
CZO has been in talks with serious partners at the AGM. 





Comment by fossi_2002on Apr 13, 2023 7:47am 
After reading through the report several times regarding the PGX demo system upgrade, I can't understand your conclusion.

For me, it is more important to develop this plant in the "right" framework. What good is it to Ceapro if it starts on too large a scale, only to find that expectations do not materialize. To me, proceeding step by step seems to be a MUST for this scale!

In the whole discussion about the pipeline of Ceapro, the development from a 10l plant to one with 50-100l is for me the most promising development point. This is where the rapid tripling of Ceapro's sales towards 2026 can be realized.

<< Previous
Bullboard Posts
Next >>